Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 9, 2012New England Journal of MedicineOpen Access

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMichel AttalUniversité de ToursVLValérie Lauwers‐CancèsUniversité Fédérale de Toulouse Midi-PyrénéesGMGérald MaritUniversité de Bordeaux

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Attal et al. (2012) studied this question.

synapsesocial.com/papers/6a7cec07537c44c1bef02ebdhttps://doi.org/10.1056/nejmoa1114138
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms2001 · 180 citations
  2. 2Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma2007 · 1,462 citations
  3. 3A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma1996 · 2,581 citations
  4. 4Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S93212006 · 498 citations
  5. 5Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma2012 · 744 citations